ProMIS Neurosciences Inc. PMN 深滬

已收盤 11-06 16:00:00 美东时间

4.16

+0.510

+13.97%

華盛通

立即下載

最高4.33
今開3.76
成交量 37.52万股
最低 3.70
昨收 3.65
總市值 3730.56万
52周最高 27.40
市盈率 ^靜 --
換手率 4.18%
52周最低 2.7801
委比 37.53%
總股本 896.77万
歷史最高 245.00
量比 0.27
振幅 17.26%
歷史最低 2.7801
每手 1
風險率 3.76%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

ProMIS Neurosciences to Participate in Upcoming Conferences in November

ProMIS Neurosciences Inc. will participate in several November 2026 conferences, including the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston, Stifel 2026 Healthcare Conference in New York, UBS Global Biopharma Conference in London, Jefferies Global Healthcare Conference in London, Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Boston, and the 9th Annual Evercore Healthcare Conference in Miami. Presentations and fir...

11-05 12:00
美股大行评级 | 潜在涨幅2250.23%！艾伯维获大摩等多家大行上调目标价，最高340美元

今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从50美元升至51美元；HC Wainwright & Co.：上调伊诺维奥制药评级至"买入"，目标价5美元

11-03 18:20
Roth Capital Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $15

Roth Capital analyst Boobalan Pachaiyappan maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and lowers the price target from $29 to $15.

11-03 02:03
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

ProMIS Neurosciences appoints Dr. Ivana Rubino as Chief Commercial Officer, bringing over 15 years of global biopharmaceutical leadership in Alzheimer’s disease, clinical development, and commercialization. Dr. Rubino will lead commercial and market preparation strategies for PMN310, a potential Alzheimer’s treatment, as the company advances toward 12-month topline data expected in Q1 2027. Her expertise will strengthen ProMIS’ capabilities in ne...

10-06 11:05
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价

今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元

08-17 13:37
Guggenheim Maintains Buy on ProMIS Neurosciences, Raises Price Target to $100

Guggenheim analyst Yatin Suneja maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $69 to $100.

08-14 21:29
ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

ProMIS Neurosciences Inc. will report second-quarter 2026 financial results and provide updates on August 13, 2026. The company will host a conference call and webcast at 4:30 p.m. ET on the same day. U.S. investors can dial 1-877-407-9208, while international participants can use 1-201-493-6784. The conference ID is 13761812. A replay will be available on the company's website. ProMIS focuses on developing antibody therapeutics targeting toxic p...

08-03 20:00
美股大行评级 | 最高1400美元！花旗、大小摩8家大行上调希捷科技目标价；大行集中调整目标价：康宁、科斯塔、思佳讯遭下调，PayPal、Visa、可口可乐、赛莱默获上调

今日重点评级关注：古根海姆：维持ProMIS Neurosciences"买入"评级，目标价从35美元升至69美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从38美元升至39美元

07-30 11:45
美股牛股 | AI基建股IOND首日升近26%，为21年来最大直接上市项目；Lucid劲升21%

AI基建股IOND首日升近26%，为21年来最大直接上市项目；医药股PMN飙升23%，阿尔茨海默病药物试验结果积极；Lucid劲升21%，获沙特首富1.3亿美元投资>>

07-29 19:00
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元

07-29 11:37

派息除權日	每股總股息	派息日期
2007-05-22	0.04	2007-06-01
2007-04-20	0.04	2007-05-01
2007-03-21	0.04	2007-04-02
2007-02-16	0.04	2007-03-01
2007-01-22	0.04	2007-02-01
2006-12-20	0.05	2007-01-02
2006-11-21	0.04	2006-12-01
2006-10-20	0.04	2006-11-01
2006-09-20	0.04	2006-10-02
2006-08-21	0.04	2006-09-01
2006-07-20	0.04	2006-08-01
2006-06-21	0.04	2006-07-03
2006-05-22	0.04	2006-06-01
2006-04-20	0.04	2006-05-01
2006-03-22	0.04	2006-04-03
2006-02-16	0.04	2006-03-01
2006-01-20	0.04	2006-02-01
2005-12-20	0.04	2006-01-03
2005-11-21	0.04	2005-12-01
2005-10-20	0.04	2005-11-01
2005-09-21	0.04	2005-10-03
2005-08-22	0.04	2005-09-01
2005-07-20	0.04	2005-08-01
2005-06-22	0.04	2005-07-01
2005-05-20	0.05	2005-06-01
2005-04-20	0.05	2005-05-02
2005-03-22	0.05	2005-04-01
2005-02-18	0.05	2005-03-01
2005-01-20	0.05	2005-02-01
2004-12-21	0.06	2005-01-03
2004-11-22	0.06	2004-12-01
2004-10-20	0.06	2004-11-01
2004-09-22	0.06	2004-10-01
2004-08-20	0.06	2004-09-01
2004-07-21	0.06	2004-08-02
2004-06-22	0.06	2004-07-01
2004-05-20	0.06	2004-06-01
2004-04-21	0.06	2004-05-03
2004-03-22	0.06	2004-04-01
2004-02-20	0.06	2004-03-01
2004-01-21	0.06	2004-02-02
2003-12-22	0.06	2004-01-02
2003-11-20	0.06	2003-12-01
2003-10-22	0.06	2003-11-03
2003-09-22	0.06	2003-10-01
2003-08-20	0.06	2003-09-02
2003-07-22	0.06	2003-08-01
2003-06-20	0.06	2003-07-01
2003-05-21	0.06	2003-06-02
2003-04-22	0.06	2003-05-01
2003-03-20	0.06	2003-04-01
2003-02-20	0.06	2003-03-03
2003-01-16	0.06	2003-02-03
2002-12-18	0.07	2003-01-02
2002-11-18	0.06	2002-12-02
2002-10-17	0.06	2002-11-01
2002-09-18	0.06	2002-10-01
2002-08-16	0.06	2002-09-03
2002-07-18	0.06	2002-08-01
2002-06-18	0.06	2002-07-01
2002-05-16	0.06	2002-06-03
2002-04-18	0.06	2002-05-01
2002-03-18	0.06	2002-04-01
2002-01-17	0.06	2002-02-01
2001-12-18	0.06	2002-01-02
2001-11-16	0.06	2001-12-03
2001-10-18	0.06	2001-11-01
2001-09-18	0.06	2001-10-01
2001-08-16	0.06	2001-09-04
2001-07-18	0.06	2001-08-01
2001-06-18	0.06	2001-07-02
2001-05-17	0.06	2001-06-01
2001-04-18	0.06	2001-05-01
2001-03-16	0.06	2001-04-02
2001-02-15	0.06	2001-03-01
2001-01-18	0.06	2001-02-01
2000-12-18	0.07	2001-01-02
2000-11-16	0.07	2000-12-01
2000-10-18	0.07	2000-11-01
2000-09-18	0.07	2000-10-02
2000-08-17	0.07	2000-09-01
2000-07-18	0.07	2000-08-01
2000-06-16	0.07	2000-07-03
2000-05-18	0.07	2000-06-01
2000-04-18	0.07	2000-05-01
2000-03-16	0.07	2000-04-03
2000-02-17	0.07	2000-03-01
2000-01-18	0.07	2000-02-01
1999-12-16	0.07	2000-01-03
1999-11-18	0.07	1999-12-01
1999-10-18	0.07	1999-11-01
1999-09-16	0.07	1999-10-01
1999-08-18	0.07	1999-09-01
1999-07-16	0.07	1999-08-02
1999-06-17	0.07	1999-07-01
1999-05-18	0.07	1999-06-01
1999-04-16	0.07	1999-05-03
1999-03-18	0.07	1999-04-01
1999-02-18	0.07	1999-03-01
1999-01-15	0.07	1999-02-01
1998-12-17	0.07	1999-01-04
1998-11-18	0.07	1998-12-01
1998-10-16	0.07	1998-11-02
1998-09-17	0.07	1998-10-01
1998-08-18	0.07	1998-09-01
1998-07-16	0.07	1998-08-03
1998-06-18	0.07	1998-07-01
1998-05-18	0.07	1998-06-01
1998-04-16	0.07	1998-05-01
1998-03-18	0.07	1998-04-01
1998-02-18	0.07	1998-03-02
1998-01-15	0.07	1998-02-02
1997-12-18	0.07	1998-01-02
1997-11-18	0.07	1997-12-01
1997-10-16	0.07	1997-11-03
1997-09-18	0.07	1997-10-01
1997-08-18	0.07	1997-09-02
1997-07-17	0.07	1997-08-01
1997-06-18	0.07	1997-07-01
1997-05-16	0.07	1997-06-02
1997-04-17	0.07	1997-05-01
1997-03-18	0.07	1997-04-01
1997-02-18	0.07	1997-03-03
1997-01-15	0.07	1997-02-03
1996-12-18	0.07	1997-01-02
1996-11-18	0.07	1996-12-02
1996-10-17	0.07	1996-11-01
1996-09-18	0.07	1996-10-01
1996-08-16	0.07	1996-09-03
1996-07-18	0.07	1996-08-01
1996-06-18	0.07	1996-07-01
1996-05-16	0.07	1996-06-03
1996-04-18	0.07	1996-05-01
1996-03-18	0.07	1996-04-01
1996-02-15	0.07	1996-03-01
1996-01-18	0.07	1996-02-01
1995-12-18	0.07	1996-01-02
1995-11-16	0.08	1995-12-01
1995-10-18	0.08	1995-11-01
1995-09-18	0.08	1995-10-02
1995-08-17	0.08	1995-09-01
1995-07-19	0.08	1995-08-01
1995-06-16	0.08	1995-07-03
1995-05-16	0.08	1995-06-01
1995-04-13	0.08	1995-05-01
1995-03-14	0.08	1995-04-03
1995-02-14	0.08	1995-03-01
1995-01-13	0.08	1995-02-01
1994-12-14	0.17	1995-01-03
1994-11-15	0.08	1994-12-01
1994-10-14	0.08	1994-11-01
1994-09-14	0.08	1994-10-03
1994-08-16	0.08	1994-09-01
1994-07-14	0.08	1994-08-01
1994-06-14	0.08	1994-07-01
1994-05-16	0.08	1994-06-01
1994-04-14	0.08	1994-05-02
1994-03-15	0.08	1994-04-04
1994-02-15	0.08	1994-03-01
1994-01-13	0.08	1994-02-01
1993-12-14	0.23	1994-01-03
1993-11-16	0.08	1993-12-01
1993-10-14	0.08	1993-11-01
1993-09-14	0.08	1993-10-01
1993-08-16	0.08	1993-09-01
1993-07-14	0.08	1993-08-02
1993-06-15	0.08	1993-07-01
1993-05-14	0.08	1993-06-01
1993-04-14	0.08	1993-05-03
1993-03-16	0.08	1993-04-01
1993-02-16	0.08	1993-03-01
1993-01-13	0.08	1993-02-01

公司名稱	ProMIS Neurosciences, Inc.
行業分類	Biotechnology
業務描述	ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

ProMIS Neurosciences Inc. PMN 深 滬

4.16

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

ProMIS Neurosciences Inc. PMN 深滬